Reaction
Retinal Drusen reporting signals
As of the last recalculation, Retinal Drusen appears in 159 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is RANIBIZUMAB (PRR 146.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranibizumab | 25 | 146.1 | 146.2 |
| Aflibercept | 13 | 59.3 | 59.3 |